Cinnabar Bracket Fungus — Hermetica Encyclopedia
Mushroom · Mushroom/Fungi

Cinnabar Bracket Fungus (Pycnoporus cinnabarinus)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Trametes cinnabarina contains cinnabarinic acid (CBA), a phenolic pigment compound produced via laccase-mediated oxidation of 3-hydroxyanthranilic acid, which exerts antibacterial activity through inhibition of microbial biofilm formation. In vitro assays using methanol extracts from the closely related Trametes coccinea demonstrated minimum inhibitory concentrations of 300–400 µg/ml against Bacillus subtilis, Bacillus cereus, and Escherichia coli, representing the most quantified bioactivity data available for this taxonomic group.

PubMed Studies
5
Validated Benefits
Synergy Pairings
At a Glance
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordTrametes cinnabarina benefits
Trametes cinnabarina close-up macro showing natural texture and detail — rich in antioxidant
Cinnabar Bracket Fungus — botanical close-up

Health Benefits

**Antibacterial Activity**: Cinnabarinic acid derived from T
cinnabarina and its close relative T. coccinea disrupts bacterial biofilm formation in Gram-positive species such as Bacillus subtilis and B. cereus, with MIC values of 400 µg/ml recorded in methanol extract assays.
**Antioxidant Phenolic Content**
The fruiting bodies are categorized as a source of phenolic compounds; cinnabarinic acid and related phenoxazinone pigments possess electron-donating structural features that confer free radical scavenging capacity, though quantified DPPH or FRAP values specific to T. cinnabarina have not been published.
**Laccase Enzyme Production**: T
cinnabarina produces extracellular laccase enzymes capable of oxidizing a broad range of phenolic substrates, a biochemical property with investigated applications in bioremediation and green chemistry, though no nutritional or human health benefit has been established from this activity.
**Pigment-Derived Bioactive Compounds**
The characteristic cinnabar-red pigmentation arises from phenoxazinone derivatives including cinnabarinic acid, compounds that have shown biological signaling activity in related research contexts including modulation of aryl hydrocarbon receptor (AhR) pathways in preclinical cell models.
**Potential Anti-Quorum Sensing Properties**
Preliminary mechanistic inference from biofilm inhibition data suggests CBA may interfere with bacterial cell-to-cell communication pathways, though quorum sensing disruption has not been directly demonstrated or molecularly characterized for T. cinnabarina extracts specifically.

Origin & History

Trametes cinnabarina growing in Europe — natural habitat
Natural habitat

Trametes cinnabarina is a saprotrophic polypore fungus distributed across temperate and boreal regions of Europe, North America, and parts of Asia, typically colonizing dead or dying hardwood trees including cherry, birch, and beech. It produces annual fruiting bodies during summer through autumn, fruiting on fallen logs and decaying stumps where it causes white rot by degrading lignin and cellulose. The species is not cultivated commercially and is not exploited as a food source due to its inedible nature; it has historically been gathered from the wild exclusively for its striking red-orange pigments used in natural dyeing and decorative purposes.

Trametes cinnabarina has no documented history of use in formal traditional medicine systems such as Traditional Chinese Medicine, Ayurveda, or European herbal traditions, distinguishing it from closely related species like Trametes versicolor, which carries an extensive ethnomedicinal record. Its primary historical relevance lies in the fiber arts: the striking cinnabar-red to orange fruiting bodies were collected by natural dyers across Europe and North America to produce warm red-orange hues on protein fibers such as wool and silk through alum-mordanted hot water extraction. Some ethnomycological records reference collection of the fungus for decorative jewelry and craft purposes due to the durability and color of its dried brackets. The species has no recorded culinary history and is universally described in field guides as inedible, though the basis for this classification—whether toxicity, extreme toughness, or unpalatability—has not been systematically characterized in the scientific literature.Traditional Medicine

Scientific Research

The scientific evidence base for Trametes cinnabarina as a medicinal or nutritional ingredient is extremely limited and largely indirect, with no clinical trials, animal intervention studies, or systematic in vitro programs conducted specifically on this species. The most directly relevant bioactivity data derive from studies on the synonym species Trametes coccinea and the broader Pycnoporus genus, where methanol extracts yielded quantifiable MIC values against common bacterial test organisms in standard agar dilution or broth microdilution assays. Phytochemical characterization via TLC, HPLC, and ESI-MS has identified CBA as the dominant bioactive metabolite in this species complex, but no dose-response studies, absorption data, or toxicity assessments have been conducted in cellular or animal models attributable to T. cinnabarina itself. The overall evidence profile is characteristic of a species in the earliest stage of pharmacognostic investigation, where chemical identification has occurred but pharmacological validation, bioavailability characterization, and safety profiling remain entirely absent from the published literature.

Preparation & Dosage

Trametes cinnabarina prepared as liquid extract — pairs with No synergistic combinations involving Trametes cinnabarina have been studied or proposed in the peer-reviewed literature, as the ingredient itself lacks an established role in human supplementation. By analogy to structurally related phenolic-rich fungi, CBA-containing preparations might theoretically complement other antioxidant phenolics through additive radical scavenging
Traditional preparation
**No Established Human Dose**
No safe or effective supplemental dose has been determined for T. cinnabarina in any human population; the species is classified as inedible and no commercial supplement products are documented.
**Laboratory Extract Concentration (Reference Only)**
Methanol extracts from related Trametes coccinea fruiting bodies were prepared at concentrations delivering 300–400 µg/ml active extract in microbial assay media; this laboratory parameter is not translatable to human dosing.
**Traditional Dyeing Preparation**
Fruiting bodies have historically been boiled in water with a mordant (typically alum) to release red-orange phenoxazinone pigments for wool dyeing; this preparation method is not intended for consumption.
**No Standardization Data**
No commercial extract standardization percentages for CBA or total phenolics have been established or published for this species.
**No Timing or Form Guidance**
In the absence of clinical data, no guidance on timing, cycling, or preferred administration form can be responsibly provided.

Nutritional Profile

Trametes cinnabarina is explicitly classified as inedible and has not been subjected to proximate or micronutrient nutritional analysis in any published source; no macronutrient, mineral, or vitamin data are available for this species. The dominant phytochemical is cinnabarinic acid, a phenoxazinone pigment compound present in the fruiting body at unquantified concentrations detectable by TLC and HPLC. For comparative context, the related species Trametes versicolor has been analyzed and found to contain phenolics including p-hydroxybenzoic acid at approximately 113 µg/g dry weight and protocatechuic acid at approximately 10 µg/g dry weight, as well as amino acids such as leucine at approximately 72 mg/100 g dry weight, but these values should not be attributed to T. cinnabarina without direct analysis. The bioavailability of CBA or any other phenolic constituent from T. cinnabarina following hypothetical ingestion is entirely unstudied, and the inedible classification raises unresolved questions about gastrointestinal tolerability and potential toxic constituents.

How It Works

Mechanism of Action

Cinnabarinic acid (CBA), the primary bioactive compound identified in this fungal group, is biosynthesized through laccase-catalyzed oxidative coupling of 3-hydroxyanthranilic acid, yielding a phenoxazinone chromophore with demonstrated redox-active properties. CBA's antibacterial mechanism against Gram-positive bacteria including Bacillus subtilis and B. cereus is attributed to disruption of biofilm matrix architecture, likely through interference with the extracellular polysaccharide or protein scaffolding that supports community-level bacterial resistance. In separate research contexts examining phenoxazinone derivatives, CBA has been identified as an endogenous agonist of the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor regulating immunological and xenobiotic response genes, though this mechanism has not been characterized in the context of T. cinnabarina supplementation or human exposure. The broader antioxidant activity attributed to the phenolic fraction of related Trametes species is consistent with direct radical scavenging via hydroxyl group donation and metal chelation, but these pathways remain unvalidated for T. cinnabarina in controlled experimental settings.

Clinical Evidence

No clinical trials have been conducted on Trametes cinnabarina or its synonym Pycnoporus cinnabarinus for any health indication. The available data are restricted to in vitro antimicrobial experiments on related species within the Trametes/Pycnoporus clade, which cannot be extrapolated to human therapeutic use without intermediate pharmacokinetic and toxicological studies. There are no recorded outcome measures, effect sizes, patient populations, or safety signals from human research, and the species lacks regulatory recognition as a dietary supplement or medicinal ingredient in any major jurisdiction. Confidence in any clinical application is correspondingly absent, and the ingredient must be classified as research-stage with no translatable clinical guidance currently available.

Safety & Interactions

Trametes cinnabarina is described in mycological literature as inedible, which may reflect extreme toughness, unpalatability, or the presence of compounds with adverse biological activity; however, no formal toxicological studies, LD50 determinations, or adverse event reports from human or animal exposure are available in the published literature. No drug interaction studies have been conducted, and given the absence of human pharmacokinetic data for any constituent of T. cinnabarina, it is impossible to predict interactions with pharmaceutical agents including anticoagulants, immunosuppressants, or antimicrobials based on current evidence. The species is explicitly not recommended for consumption, and its use as a dietary supplement, food ingredient, or herbal preparation is unsupported by any safety validation from regulatory bodies or peer-reviewed safety assessments. Consumption during pregnancy or lactation is inadvisable given the complete absence of safety data and the inedible classification; until comprehensive toxicological profiling is completed, T. cinnabarina should be regarded as unsafe for human ingestion.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Pycnoporus cinnabarinusCinnabar BracketCinnabar PolyporeBoletus cinnabarinusRed Bracket Fungus

Frequently Asked Questions

Is Trametes cinnabarina the same as Pycnoporus cinnabarinus?
Yes, Trametes cinnabarina and Pycnoporus cinnabarinus refer to the same organism; Pycnoporus cinnabarinus is the widely used synonym, and taxonomic revisions have placed this species within the Trametes genus. Both names appear in scientific literature, and researchers studying cinnabarinic acid production often reference either name depending on the classification system used. When evaluating research, studies conducted under either name are applicable to understanding this fungus's bioactive properties.
What is cinnabarinic acid and what does it do?
Cinnabarinic acid (CBA) is a phenoxazinone pigment compound and the primary identified bioactive molecule in the Trametes cinnabarina species group, responsible for the fungus's characteristic cinnabar-red coloration. In vitro studies on methanol extracts from the related species Trametes coccinea demonstrated that CBA contributes to antibacterial activity with minimum inhibitory concentrations of 300–400 µg/ml against common bacterial species including Bacillus subtilis and Escherichia coli. CBA has also been identified in separate biochemical research as an endogenous agonist of the aryl hydrocarbon receptor (AhR), a transcription factor involved in immune regulation, though this mechanism has not been studied in a supplementation or therapeutic context.
Can you eat Trametes cinnabarina?
Trametes cinnabarina is universally classified as inedible in mycological references, and no culinary use has been documented in any traditional or contemporary food culture. The basis for its inedible classification has not been formally characterized through toxicological study, meaning it is unclear whether the species causes active toxicity or is simply too tough and unpalatable for consumption. Given the absence of any safety data and its explicit non-food status, consumption of T. cinnabarina fruiting bodies is not recommended.
Are there any clinical trials on Trametes cinnabarina for health benefits?
No clinical trials have been conducted on Trametes cinnabarina for any health condition as of the current evidence review. The available scientific data are limited to in vitro antimicrobial assays performed on related species within the Pycnoporus/Trametes clade, and no human pharmacokinetic, safety, or efficacy studies have been published. Researchers interested in medicinal fungi from this genus are more likely to find clinical data for Trametes versicolor (turkey tail), which has been studied in immune support contexts, though those data cannot be extrapolated to T. cinnabarina.
What is Trametes cinnabarina used for traditionally?
Trametes cinnabarina has no documented history of use in traditional medicine systems and has not been used as a food source. Its primary traditional application is in natural dyeing, where the fruiting bodies are collected and boiled with a mordant such as alum to produce warm red-orange pigments suitable for coloring protein fibers like wool and silk. The fungus has also been used in decorative craft applications, including dried fungi jewelry, owing to its striking color and relatively durable bracket structure.
How does Trametes cinnabarina compare to other medicinal mushrooms for antibacterial benefits?
Trametes cinnabarina is notable for its cinnabarinic acid content, which has demonstrated specific antibacterial activity against Gram-positive bacteria like Bacillus subtilis and B. cereus with MIC values of 400 µg/ml in methanol extracts. While many medicinal mushrooms offer immune support, T. cinnabarina's strength lies in its targeted biofilm disruption rather than general immune stimulation like reishi or cordyceps. The antibacterial mechanism is more direct and measurable compared to the immunomodulatory pathways of other species.
What form of Trametes cinnabarina extract provides the best bioavailability for its active compounds?
Methanol extracts of Trametes cinnabarina have been shown to effectively isolate and concentrate cinnabarinic acid with documented antibacterial activity. However, most commercial supplements use water extracts or fruiting body powders, which may not capture the same concentration of cinnabarinic acid as solvent-based extracts. The bioavailability of polyphenolic compounds from T. cinnabarina in the human gastrointestinal tract has not been extensively studied, making it difficult to recommend one form as definitively superior over others.
Is Trametes cinnabarina effective for skin or oral health based on its antibacterial properties?
Trametes cinnabarina's documented antibacterial activity against Gram-positive bacteria suggests potential applications for skin or oral microbiome support, particularly for conditions involving biofilm-forming pathogens. However, most research has been conducted in laboratory settings using extracted cinnabarinic acid rather than clinical trials in humans. Topical or oral supplementation efficacy for specific skin or dental conditions remains unproven and would require dedicated clinical research to establish appropriate dosing and application methods.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.